My PCR
Create Account
Logo PCR

16 May 2024

Left main and multivessel diseaseStents, scaffolds and DCB

Drug coated balloon PCI in complex scenarios

Session comprising selected EuroPCR 2024 Clinical Case submissions

Facilitators: Z. Ghazzal, T. K. Ong, A. swamy
Speakers: C. Jensen, S.S. Kanoun Schnur, M. Kovacevic, E. Poulidakis, T. Rissanen, A. Wong, D. Zioutas, C. F. Vigo

Summary

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the use of drug-coated balloons (DCB) in complex PCI scenarios. It covers various case presentations and discussions, including the use of DCB in left main PCI, 2-year angiographic follow-up after left anterior descending artery PCI using a novel sirolimus-coated balloon, and the hybrid treatment of an ectatic vessel using DCB.

Presentations available when logged in:

  • 2 years angiographic follow-up after left anterior descending artery PCI using novel sirolimus-coated balloon with microreservoirs
  • Non-metal treatment of medina 0/0/1 bifurcation lesion
  • Optimising care. Left main trifurcation challenges
  • IVUS guided DEB
  • Drug coated balloon-changing the treatment paradigm
  • Adapting the culotte: from bench test to in-vivo case series
  • Hybrid treatment of an ectatic vessel. When normal sized stents are not enough
Related Content
Sirolimus-Eluting Balloon vs. Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary... A novel bailout technique for the percutaneous extraction of an entrapped coronary guidewire beneath a crushed stent The next frontier of DCB is to simplify complexity
Recommended for you
IVUS vs angiography in unprotected left main PCI IRONMAN II: 2-year outcomes of sirolimus-eluting bioresorbable scaffolds vs. DES OPTION-STEMI